Further validation in recruited subjects also confirmed a higher negative correlation of IGFBP2 with LVEF and a positive correlation with LVIDD, suggesting that this gene is a key biomarker of left ventricle dysfunction in DCM patients. The gene discussed is IGFBP2; the disease is familial dilated cardiomyopathy.